Clinical Trial Update: Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing standard versus adjusted dosing of piperacillin/tazobactam in patients with acute renal failure and septic shock was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure
• Septic Shock

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Fraser Health | Conditions: Septic Shock, Acute Renal Failure | Phase 4 | Status: TERMINATED